Calendar
FDA meetings and decisions
Upcoming FDA advisory committee meetings and decision dates for drugs in review.
What is a PDUFA date?
Under the Prescription Drug User Fee Act, the FDA sets a deadline for its decision on each new drug application: usually six months for a priority review and ten months for a standard one. On that date the FDA approves the drug, sends a Complete Response Letter asking for more, or extends the review.
Companies announce these dates in their filings and press releases, so they are known in advance. Share prices of smaller biotech companies often move sharply on the outcome.
What is an advisory committee?
For new or debated drugs, the FDA asks a panel of outside doctors and statisticians to review the evidence and vote on safety and effectiveness. The FDA usually follows the vote, though it doesn’t have to. Only about one application in ten goes to a panel.
Where the dates come from
Advisory committee meetings are found automatically in FDA notices published in the Federal Register.
PDUFA dates are added by hand from company filings and press releases, because the FDA doesn’t publish them in one list. Past entries drop off after a week.
Dates can be moved, cancelled or brought forward by the FDA without notice. Check the company’s latest filing before relying on one.